We Think Zimmer Biomet Holdings' (NYSE:ZBH) Profit Is Only A Baseline For What They Can Achieve
We Think Zimmer Biomet Holdings' (NYSE:ZBH) Profit Is Only A Baseline For What They Can Achieve
Even though Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) recent earnings release was robust, the market didn't seem to notice. Our analysis suggests that investors might be missing some promising details.
尽管 Zimmer Biomet Holdings, Inc.s(纽约证券交易所代码:ZBH)最近发布的财报表现强劲,市场似乎没有注意到。我们的分析表明,投资者可能遗漏了一些令人鼓舞的细节。
How Do Unusual Items Influence Profit?
不寻常的物品如何影响利润?
Importantly, our data indicates that Zimmer Biomet Holdings' profit was reduced by US$200m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Zimmer Biomet Holdings to produce a higher profit next year, all else being equal.
重要的是,我们的数据表明,由于不寻常的项目,Zimmer Biomet Holdings的利润比去年减少了2亿美元。看到不寻常的项目使公司利润损失从来都不是一件好事,但从好的方面来看,情况可能迟早会好转。我们调查了数千家上市公司,发现不寻常的物品本质上往往是一次性的。而且,毕竟,这正是会计术语的含义。假设这些不寻常的支出不会再次出现,因此,我们预计Zimmer Biomet Holdings在其他条件相同的情况下,明年将实现更高的利润。
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
这可能会让你想知道分析师对未来盈利能力的预测。幸运的是,您可以单击此处查看根据他们的估计描绘未来盈利能力的交互式图表。
Our Take On Zimmer Biomet Holdings' Profit Performance
我们对Zimmer Biomet Holdings盈利表现的看法
Unusual items (expenses) detracted from Zimmer Biomet Holdings' earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Zimmer Biomet Holdings' statutory profit actually understates its earnings potential! And on top of that, its earnings per share have grown at an extremely impressive rate over the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. While conducting our analysis, we found that Zimmer Biomet Holdings has 1 warning sign and it would be unwise to ignore it.
不寻常的项目(支出)减少了Zimmer Biomet Holdings去年的收益,但明年我们可能会看到改善。基于这一观察,我们认为Zimmer Biomet Holdings的法定利润实际上可能低估了其盈利潜力!最重要的是,其每股收益在过去一年中以极其惊人的速度增长。归根结底,如果你想正确地了解公司,必须考虑的不仅仅是上述因素。因此,如果你想更深入地研究这只股票,那么考虑它面临的任何风险至关重要。在进行分析时,我们发现Zimmer Biomet Holdings有1个警告信号,忽视它是不明智的。
Today we've zoomed in on a single data point to better understand the nature of Zimmer Biomet Holdings' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.
今天,我们放大了单一数据点,以更好地了解Zimmer Biomet Holdings利润的性质。但是,如果你能够将注意力集中在细节上,总会有更多的事情需要发现。例如,许多人认为高股本回报率是有利的商业经济的标志,而另一些人则喜欢 “关注资金”,寻找内部人士正在买入的股票。因此,你可能希望看到这份免费收藏的拥有高股本回报率的公司,或者这份内部人士正在购买的股票清单。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。